Lv51
1140 积分 2025-05-08 加入
VENETOCLAX COMBINED WITH INTENSIVE CHEMOTHERAPY REGIMENS FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA. A SYSTEMATIC REVIEW AND SINGLE-ARM META- ANALYSIS
1小时前
求助中
Venetoclax Combined With Intensive Chemotherapy Regimens for Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Systematic Review and Single-Arm Meta-Analysis
1小时前
已完结
CD40 promotes AML survival via non-canonical NF-κB signaling and aberrant lipid metabolism
1天前
待确认
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
4天前
已完结
Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile
7个月前
已完结
Mesenchymal Stromal Cell-Derived MMP14 Facilitates Leukemia Progression and Chemotherapy Resistance
7个月前
已关闭
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients
7个月前
已完结
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax‐based therapy in the real world: Hokkaido Leukemia Net Study
8个月前
已完结
How I treat patients with AML using azacitidine and venetoclax
8个月前
已完结
Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group
9个月前
已完结
皖公网安备34019202002308
